The DOI matches its Crossref record; 182 of the 184 references it cites were found in a registry or an index.
The role of JAK/STAT signaling pathway and its inhibitors in diseases.
Abstract
The JAK/STAT signaling pathway is an universally expressed intracellular signal transduction pathway and involved in many crucial biological processes, including cell proliferation, differentiation, apoptosis, and immune regulation. It provides a direct mechanism for extracellular factors-regulated gene expression. Current researches on this pathway have been focusing on the inflammatory and neoplastic diseases and related drug. The mechanism of JAK/STAT signaling is relatively simple. However, the biological consequences of the pathway are complicated due to its crosstalk with other signaling pathways. In addition, there is increasing evidence indicates that the persistent activation of JAK/STAT signaling pathway is closely related to many immune and inflammatory diseases, yet the specific mechanism remains unclear. Therefore, it is necessary to study the detailed mechanisms of JAK/STAT signaling in disease formation to provide critical reference for clinical treatments of the diseases. In this review, we focus on the structure of JAKs and STATs, the JAK/STAT signaling pathway and its negative regulators, the associated diseases, and the JAK inhibitors for the clinical therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A member of its family, the JAK2/STAT3 signal pathway, is involved in neuronal death and nervous reorganization in ischemic encephalopathy [62].”
Citations
Cites
1 retracted
Ling, L., Zhang, S., Zhi, L.-D., Li, H., Wen, Q.-K., Li, G., & Zhang, W. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.05.042 · Cited by 31
RetractedSTATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383
Epidemiology of Parkinson's disease
de Lau, L. M., & Breteler, M. M. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70471-9 · Cited by 4,110
Darnell, J. E. (1997) · Science · doi:10.1126/science.277.5332.1630 · Cited by 3,979
Scott, D. L., Wolfe, F., & Huizinga, T. W. J. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60826-4 · Cited by 3,263
Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy
Hotchkiss, R. S., Monneret, G., & Payen, D. (2013) · Nature Reviews Immunology · doi:10.1038/nri3552 · Cited by 2,772
High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
Lotze, M. T., & Tracey, K. J. (2005) · Nature reviews. Immunology · doi:10.1038/nri1594 · Cited by 2,490
A quantitative analysis of kinase inhibitor selectivity
Karaman, M. W., Herrgard, S., Treiber, D. K., Gallant, P., Atteridge, C. E., Campbell, B. T., Chan, K. W., Ciceri, P., Davis, M. I., Edeen, P. T., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1358 · Cited by 2,466
Epidemiology of Parkinson’s disease
Tysnes, O., & Storstein, A. M. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1686-y · Cited by 2,437
The STATs of cancer — new molecular targets come of age
Yu, H., & Jove, R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1275 · Cited by 2,278
Flagged first, then by citations
2 of the 184 references couldn’t be matched to a known paper.
Research works printed but not linked: 3
- Seif, 2017, The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells, Cell Commun. Sign., 15, 1
- Oshea, 2015, The JAK-STAT pathway: impact on human disease and therapeutic intervention*, Annu. Rev. Med., 66, 311, 10.1146/annurev-med-051113-024537 · DOI
- Yan, 2018, Role of the JAK/STAT signaling pathway in regulation of innate immunity in neuroinflammatory diseases, Clin. Immunol., 189, 4, 10.1016/j.clim.2016.09.014 · DOI · Paper page
Cited by
Sorted by citations
Items 601–700 of 1,000
Matsumoto, M., Uchida, K., Tazawa, R., Kenmoku, T., Inoue, K., Inoue, G., & Takaso, M. (2025) · JSES International · doi:10.1016/j.jseint.2025.05.021 · Cited by 4
Zhang, J., Xing, S., Cui, J., Wei, X., Cao, Z., Shao, B., Jiang, N., & Zhai, X. (2024) · Archiv der Pharmazie · doi:10.1002/ardp.202300591 · Cited by 4
Miao, J., Chen, S., Cao, H., Ding, Z., Li, Y., Wang, W., Nundlall, K., Deng, Y., & Li, J. (2024) · Molecular Carcinogenesis · doi:10.1002/mc.23714 · Cited by 4
Role of miRNAs in macrophage-mediated kidney injury
Li, J., Yan, X., Wu, Z., Shen, J., Li, Y., Zhao, Y., Du, F., Li, M., Wu, X., Chen, Y., et al. (2024) · Pediatric Nephrology · doi:10.1007/s00467-024-06414-5 · Cited by 4
Elucidating the Signaling Pathways Involved in Erectile Dysfunction
Kaya‐Sezginer, E., Celik, A., & Kırlangıç, O. F. (2024) · Current Signal Transduction Therapy · doi:10.2174/0115743624302323240522101746 · Cited by 4
Zhu, X., & Wu, W. (2024) · Skin Research and Technology · doi:10.1111/srt.13858 · Cited by 3
RetractedLin, C., Chiang, Y.-T., Lin, L.-Y., Tsao, N., Wang, C.-H., Chien, S.-C., Sun, Y., & Wang, S. (2024) · Plants · doi:10.3390/plants13172506 · Cited by 4
Niu, Y., Feng, Q., Cui, M., Fan, C., Wang, T., Yuan, R., Dikye, T., Huang, S., & Li, B. (2024) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b24-00362 · Cited by 5
Kumar, N., Tyagi, N., Mehan, S., & Singh, A. P. (2024) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273336107241015100912 · Cited by 5
Liu, X., Cheng, J., Tang, M., Liao, C., Yang, Y., Luo, M., Xu, L., Zhong, X., Ma, Q., & Guo, X. (2025) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2025.107051 · Cited by 4
Lu, J., Yin, Z., Qiu, Y., Yang, Y., Chen, Z., Wu, J., & Wang, Z. (2025) · Biomedicines · doi:10.3390/biomedicines13040957 · Cited by 4
Abdelaziz, H. M., Abdelmageed, M. E., & Suddek, G. M. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177832 · Cited by 5
The combination of PRL-3 inhibitor with sorafenib synergistically promotes AML apoptosis
Chen, X., Rong, D., Cai, W., Tong, X., & Wang, H. (2021) · Neoplasma · doi:10.4149/neo_2021_210301n265 · Cited by 4
Emerging protein kinase inhibitors for the treatment of rheumatoid arthritis
Palominos, P. E., Lineburger, I. B., & Xavier, R. M. (2021) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2021.1964472 · Cited by 4
Gu, H., Chen, S., Zhang, M., Wen, Y., & Li, B. (2022) · PeerJ · doi:10.7717/peerj.12781 · Cited by 4
Liu, L., Shi, Y., Lai, Q., Huang, Y., Jiang, X., Liu, Q., Huang, Y., Xia, Y., Xu, D., Jiang, Z., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.865909 · Cited by 4
Miyake, S., & Masuda, S. (2022) · RNA Biology · doi:10.1080/15476286.2022.2146919 · Cited by 4
The Spliceosome Factor EFTUD2 Promotes IFN Anti-HBV Effect through mRNA Splicing
Hu, P., Li, Y., Zhang, W., Liu, R., Peng, L., Xu, R., Cai, J., Yuan, H., Feng, T., Tian, A., et al. (2023) · Mediators of Inflammation · doi:10.1155/2023/2546278 · Cited by 4
LI, M., ZHENG, Z., Ke, J., LUO, J., Jiang, F., QU, Y., Zhu, B., Li, Y., & Zuo, L. (2023) · Biocell · doi:10.32604/biocell.2023.027971 · Cited by 4
The dual functions of KDM7A in HBV replication and immune microenvironment
Yang, D., Tian, R., Deng, R., Xue, B., Liu, S., Wang, L., Li, H., Liu, Q., Wan, M., Tang, S., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.01641-23 · Cited by 4
Self-citationWang, W., Pan, C., Lai, Q., Zhang, Q., & Chen, J. (2023) · Aquaculture · doi:10.1016/j.aquaculture.2023.740139 · Cited by 4
Zhang, Y., Song, Y., Zhang, J., Li, L., He, L., Bo, J., Gong, Z., & Xiao, W. (2023) · Food and Chemical Toxicology · doi:10.1016/j.fct.2023.114095 · Cited by 4
Ma, M., Qian, T., & Li, C. (2023) · Dermatologica Sinica · doi:10.4103/ds.ds-d-23-00156 · Cited by 4
Wang, J., Wei, W., Xing, C.-H., Wang, H., Liu, M., Xu, J., He, X., Liu, Y., Guo, X., & Jiang, R.-S. (2024) · Animals · doi:10.3390/ani14010173 · Cited by 4
Shi, A., Yun, F., Shi, L., Liu, X., & Jia, Y. (2024) · Annals of Medicine · doi:10.1080/07853890.2024.2329130 · Cited by 5
The Role of Signaling Pathway in the Biological Cause of Rheumatoid Arthritis
Chauhan, R. K., Sharma, P. K., & Srivastava, S. (2020) · Current Drug Research Reviews · doi:10.2174/2589977512999201109215004 · Cited by 4
Szczotko, M., Antunes, S., Domingos, A., & Dmitryjuk, M. (2025) · Scientific Reports · doi:10.1038/s41598-025-87506-6 · Cited by 3
Zhang, K., Dai, X., Chen, W., Li, X., Wang, Y., Chen, Y., Qiao, Y., Chen, Y., Duan, X., Zhao, J., et al. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115042 · Cited by 3
Self-citationMechanisms and Recent Advances of Small-Molecule Therapeutics in Rosacea Treatment
Ye, M., Hao, P., Luo, N., & Li, T. (2025) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s525787 · Cited by 3
Nourbakhsh, S. T., Mohamadhashem, F., Fard, E. S., Mohamadhashem, F., & Daraei, A. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101793 · Cited by 3
Zhang, W., Huang, S., Guo, A., Zhao, Z., Zhang, B., Li, F., Bao, H., & Zhang, H. (2025) · Poultry Science · doi:10.1016/j.psj.2025.105747 · Cited by 3
Hao, H., Yuan, C., Zhang, C., & Jian, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1632803 · Cited by 3
Wu, H., Chen, S.-Y., Yuan, D.-L., & Zhao, T. S. (2025) · PLoS ONE · doi:10.1371/journal.pone.0335057 · Cited by 3
Fan, T., Li, L., Wang, Y., Meng, L., & Wu, F. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1690124 · Cited by 3
Self-citationThe role of PPARγ in cancer cachexia: friend or foe?
Ding, L., Jiang, H., Shen, L., & Xu, Y. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1717134 · Cited by 4
Singh, N. K., & Solanki, K. (2025) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70656 · Cited by 3
Liu, H.-C., Zhang, A., Shi, M.-Y., Zhang, J., Zhang, T., Lu, W., Zhang, M.-Z., Zhang, Z., Wu, Y., Miao, Y., et al. (2025) · Stem cell research & therapeutics · doi:10.1186/s13287-025-04789-2 · Cited by 3
Prostate Cancer, JAK/STAT3 Dysregulation, and Flavonoids: Is There a Possible Link?
Uivaroşi, V., Miricescu, D., Văcăroiu, I. A., Spinu, D. A., Ștefani, C., Stanciu, S., Nica, R. I., Stănescu-Spînu, I.-I., Bădoiu, S. C., Nica, S., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27020885 · Cited by 3
Anti-inflammatory properties of Dendrobium: A systematic review of pharmacological mechanisms
Yang, B.-Q., Tang, C.-Y., He, T.-T., He, T.-T., Luo, H.-L., Shi, Z.-M., Yang, S.-Y., & Tang, J. (2026) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2026.121234 · Cited by 3
Fu, G., Tang, S., Sun, X., Tong, J., Zhou, M., Li, P., Meng, P., Cheng, S., & Zhenyan, S. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1763180 · Cited by 4
The role of JAK3 and TEC family kinases in vitiligo pathogenesis
Passeron, T., Sénéschal, J., Picardo, M., Xiang, L. F., Tanemura, A., Winkler, A. R., Telliez, J., & Adiri, R. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1662245 · Cited by 3
Yao, L., Yan, R., & Sun, C. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1819436 · Cited by 4
A Mini-review on Helicobacter pylori with Gastric Cancer and Available Treatments
Jacob, T. V., & Doshi, G. (2023) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530323666230824161901 · Cited by 3
Malik, S., Fatima, B., Hussain, D., Imran, M., Chohan, T. A., Khan, M. S., Majeed, S., & Haq, M. N. U. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01390-y · Cited by 3
Jyonouchi, H. (2023) · Journal of Translational Genetics and Genomics · doi:10.20517/jtgg.2023.32 · Cited by 3
Zhang, J., Wang, H., Wang, Q., Mo, J., Fu, L., & Peng, S. (2024) · Mammalian Genome · doi:10.1007/s00335-024-10078-9 · Cited by 3
Unveiling the Complexities: Exploring Mechanisms of Anthracyclineinduced Cardiotoxicity
Tayal, R., Mannan, A., Singh, S., Dhiman, S., & Singh, T. G. (2024) · Current Cardiology Reviews · doi:10.2174/011573403x322928241021100631 · Cited by 3
Aluminum Induces Neurotoxicity through the MicroRNA-98-5p/Insulin-like Growth Factor 2 Axis
He, C., Hu, Q., Liu, C., Chu, Y., Jia, J., Zhang, X., & Niu, Q. L. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00429 · Cited by 3
Nadukkandy, A. S., Blaize, B., Kumar, C. D., Mori, G., Cordani, M., & Kumar, L. D. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.111605 · Cited by 4
A Review on the Mechanisms and Clinical Advances of JAK Inhibitors in the Treatment of Rosacea
Hu, Y., Li, B., Hu, R., Huang, C., & Huang, K. (2025) · Journal of Cutaneous Medicine and Surgery · doi:10.1177/12034754251325482 · Cited by 3
Refaie, M. M. M., Abdel‐Hakeem, E. A., Ibrahim, R., Mohamed, Z. H., Shehata, S., Bakry, H. S. S. E., & Ali, D. M. E. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70092 · Cited by 4
Xu, M., Han, S., Yang, M., Chen, J., Liu, Y., Zhou, Y., & Shi, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-06017-6 · Cited by 3
Advances of HDAC dual inhibitors in breast cancer treatment.
Wu, C.-J., Wu, J.-Y., Ni, L., Liang, M., Feng, R., Kong, X., Zhou, H.-L., & Nie, J. (2025) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2025.118372 · Cited by 3
Extracellular Vesicles and Vascular Inflammation
Yu, P., Deng, S., Yuan, X., Pan, J., & Xu, J. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-99-1443-2_7 · Cited by 3
JAK1 inhibitor: A promising option for patients with pigmented purpuric dermatoses
Cao, S., Liu, Y., Chen, S., Zhao, Q. S., Xue, X., Huai, P., & Zhang, F. (2023) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.19616 · Cited by 3
Liu, X., Wang, B., Liu, Y., Yu, Y., Wan, Y., Wu, J., & Wang, Y. (2023) · Molecular Diversity · doi:10.1007/s11030-023-10742-3 · Cited by 3
Self-citationRen, G., Han, J., Mo, J., Xu, Z., Feng, X., Chen, F., Wu, Y., & Peng, Q. (2024) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303266951231206114153 · Cited by 3
STAT transcription factor is indispensable for oogenesis in silkworm
Wang, S., Zhou, L., Liang, W., Li, S., Zou, Y., Xuan, Q., Zhao, P., Xia, Q., & Lu, Z. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.133864 · Cited by 3
Lin, J., Wang, D., Zhou, J., Bai, J., Sun, S., Jia, X., Liang, X., Fu, S., & Yu, J. (2024) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2024.106666 · Cited by 3
Self-citationLee, Y. S., Jhun, J., Choi, J. W., Hwang, S., Woo, J. S., Lee, K. H., Yang, S. C., Lee, A. R., & Cho, M. (2024) · Immunology Letters · doi:10.1016/j.imlet.2024.106935 · Cited by 3
FoxO1 promotes high glucose-induced inflammation and cataract formation via JAK1/STAT1
Li, Y., Pan, A.-P., Ye, Y., Shao, X. H., Tu, R., Liu, Y., & Yu, A. (2025) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-025-06744-6 · Cited by 3
The prospect and underlying mechanisms of Chinese medicine in treating periodontitis
Xing, A., Wang, F., Liu, J., Zhang, Y., He, J., Zhao, B., & Sun, B. (2025) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(25)60842-9 · Cited by 3
Mechanisms of Radiation-induced Brain Injury in Mice Based on Bioinformatics Analysis
Liu, P., Fu, M., Liu, D., Chao, T., & Zhang, J. (2025) · Radiation Research · doi:10.1667/rade-24-00204.1 · Cited by 6
Circulating miR-548c-3p possesses good diagnostic potential for metabolic syndrome
Dandare, A., Liaquat, A., Rafiq, M., Javeres, M. N. L., Younis, S., & Khan, M. J. (2022) · Genes & Diseases · doi:10.1016/j.gendis.2022.06.008 · Cited by 3
Expression and prognosis analysis of PAQR5 in kidney cancer
Lu, T., Xu, H., Dong, W., & Dong, H. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.955510 · Cited by 3
Changes in microglia during drug treatment of stroke
Zhang, L., Zhou, H., Wang, S., Guan, Y., Zhang, C., & Fang, D. (2022) · Ibrain · doi:10.1002/ibra.12037 · Cited by 3
Bargaining and Argument-Based Negotiation: .
Rahwan, I., Sonenberg, L., & McBurney, P. (2004) · Cited by 3
Biochemical basis of endocrinology (I) receptors and signal transduction
Blanco, A., & Blanco, G. V. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91599-1.00010-9 · Cited by 2
Zhang, X., Rao, M., & Gao, P. (2024) · Journal of Proteomics · doi:10.1016/j.jprot.2024.105085 · Cited by 2
Research on the Action and Mechanism of Pharmacological Components of Omphalia lapidescens
Xu, K., Wang, L., & He, D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011016 · Cited by 2
Traditional Chinese Herbal Medicine: Therapeutic Potential in Chronic Obstructive Pulmonary Disease
Shi, Q., Liu, X., Shengbu, M., Jiaqiu, S., & Lai, X. (2024) · Natural Product Communications · doi:10.1177/1934578x241293922 · Cited by 2
Alzahrani, K. J., Safadi, M. E., Alzahrani, F. M., Akbar, A., & Alsiwiehri, N. O. (2025) · Tissue and Cell · doi:10.1016/j.tice.2025.102735 · Cited by 2
Yang, I., Jeong, N., Choi, Y., Choi, D. K., Lee, H., Kwon, T. K., Lee, S., & Kim, S. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.117926 · Cited by 2
Unraveling the role of miR-767 in tumor progression: Mechanisms and clinical implications
Fu, Z., Jin, C., Yu, S., Xu, H., Zhang, H., Qiu, M., Dong, J., & Duan, S. (2025) · Gene · doi:10.1016/j.gene.2025.149366 · Cited by 2
Challenging the “Undruggable”─Targeting STAT3 but Identifying Potent TrkA-Targeted Inhibitors
Iliev, P., McCutcheon, C., Admas, T. H., Reithmeier, A., McDonald, M. C. L., Outryve, A. V., Hanke, D., Brown, J. I., Haraldsson, M., Toillon, R., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c00214 · Cited by 2
JAK Inhibitor and Crohn’s Disease
Xu, M., Wang, S., Xu, S., & Gong, R. (2025) · Biomedicines · doi:10.3390/biomedicines13061325 · Cited by 4
A Case of Intense Pulsed Light Aggravated Rosacea Successfully Treated by Abrocitinib
Mao, L., Xiong, L., Deng, Y., & Xiong, X. (2025) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s522317 · Cited by 2
Deficiency of IFNAR1 Increases the Production of Influenza Vaccine Viruses in MDCK Cells
Wang, Q., Chen, T., Feng, M., Zheng, M., Gao, F., Qiu, C., Luo, J., & Li, X. (2025) · Viruses · doi:10.3390/v17081097 · Cited by 2
Wang, S., Zhu, H., Zhan, W., Hao, B., Li, Z., & Zhang, T. (2025) · Clinical & Translational Oncology · doi:10.1007/s12094-025-04025-6 · Cited by 2
Harnessing Natural Compounds in Psoriasis: Targeting Cellular Pathways for Effective Therapy
Lee, H. J., So, Y. J., Jo, I., Jang, J. Y., Yook, T. H., Lee, J. H., Kim, S. W., Lee, K., Park, S.-J., & Yang, G. (2025) · Phytotherapy Research · doi:10.1002/ptr.70085 · Cited by 2
Wang, X., Jiang, M.-T., Bao, H., Huang, R.-Z., Chen, B., Wu, C.-F., Wang, H., Luo, Z.-H., & Li, W. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117306 · Cited by 6
Li, W., Zhang, X., Shen, J., & Weng, X. (2025) · Animals · doi:10.3390/ani15192824 · Cited by 2
Ma, K., Feng, M., Qiao, A., Li, L., & Wang, X. (2025) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-025-09085-x · Cited by 2
He, Y., Wang, J., Ying, C., Liang, W., Yin, Z., Gao, J., Wang, B., Zhao, X., & Zhang, Y. (2025) · Medicine · doi:10.1097/md.0000000000044392 · Cited by 2
Rime algorithm with partial reinforcement and edge strategies for lupus nephritis image segmentation
Huang, J., Heidari, A. A., Liu, L., Shao, Q., Chen, H., & Chen, X. (2025) · Applied Soft Computing · doi:10.1016/j.asoc.2025.114178 · Cited by 2
Zhao, D., Wang, Y., He, T., Chen, Y., Bai, Y., Huang, Y., Ding, K., Ma, J., & Zhang, L. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1685674 · Cited by 2
Self-citationYang, K., He, Y., Leng, J., Lu, T., Wang, Y., Xie, K., Song, T., Chen, Z., & Zhang, L. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05464-6 · Cited by 2
Self-citationRole and regulation of kinases in age-related macular degeneration
Fang, J., Huang, Y., Li, B., & Du, Y. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-025-07669-8 · Cited by 2
Duboëlle, M., Lercara, A., Pers, Y., Michel, C., Lepelley, M., Valnet‐Rabier, M., Faillie, J., Brès, V., & Palassin, P. (2026) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.70072 · Cited by 2
Revisiting Janus kinases as molecular drug targets for rheumatic diseases
Kwon, S. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1716179 · Cited by 2
Meng, G., Wang, M., Sun, C., Feng, G., Ren, J., Feng, S., & Wang, Y. (2026) · Blood and Lymphatic Cancer Targets and Therapy · doi:10.2147/blctt.s574445 · Cited by 2
Self-citationGhosh, S., Chaudhuri, R., Mukherjee, M., Samanta, A., Saha, P., Henneman, L., Majumdar, D., Sengupta, M. R., Chakraborty, A., Maiti, B., et al. (2026) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2026.02.006 · Cited by 2
Liu, J.-B., Li, S., Sun, G.-S., Zhao, R., Liu, H., Lin, Z., Shan, P.-F., Yang, W., & Miao, Z. (2026) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c17487 · Cited by 3
Dai, X. D., Wu, Y., Lian, L., 崔振宇, 崔振宇, & Wu, Y. (2026) · Chinese Herbal Medicines · doi:10.1016/j.chmed.2026.05.007 · Cited by 2
Cellular crosstalk and signaling networks in the rheumatoid arthritis synovial microenvironment
Feng, M., Chen, H. H., Liao, L., Huang, D., Shen, J., Xiao, L., Lu, Q., & Xie, P. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08482-7 · Cited by 2
Kumar, A., Soratur, A., Kumar, S., Sarkar, A., Thiruchitrambalam, G., & Maran, B. A. V. (2026) · Discover Oceans · doi:10.1007/s44289-026-00161-1 · Cited by 2
Mirfakhraie, R., Ardakani, M. T., Hajifathali, A., Karami, S., Moshari, M. R., Hassani, M., Firouz, S. M., & Roshandel, E. (2022) · Transplant Immunology · doi:10.1016/j.trim.2021.101524 · Cited by 2
Janus kinase inhibitors - their current applications and future prospects
Wierzbowska, N., Żurawska, K., Arciszewski, M., Kukowka, A., & Banach, B. (2022) · Farmacja Polska · doi:10.32383/farmpol/153914 · Cited by 2
Liu, J., Wang, K., Ji, H., Zhang, G., Chen, S., Zhang, S., Lu, F., & Hu, C. (2022) · Frontiers in Surgery · doi:10.3389/fsurg.2022.983958 · Cited by 2
Güner, T. A. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub128.c509 · Cited by 2
Metadata
- Authors
- Xin, P., Xu, X., Deng, C., Liu, S., Wang, Y., Zhou, X., Ma, H., Wei, D., & Sun, S.
- Affiliations
- Harbin Medical University (CN)
- China Pharmaceutical University (CN)
- Southeast University (CN)
- Corresponding author
- Sun, Shiqin
- Venue
- International Immunopharmacology
- Publisher
- Elsevier BV
- Published
- 2020-03
- Volume
- 80
- Pages
- 106210
- ISSN
- 1567-5769 (ISSN-L)
- OpenAlex
- W3001733563
- Cited by
- 1,010
- References
- 184
- Citations by year
- 2026: 125 · 2025: 229 · 2024: 224 · 2023: 195 · 2022: 160 · 2021: 56 · 2020: 20
- FWCI
- 11.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- International Immunopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Fundamental Research Funds for the Central Universities (2018XN-25, JFWLD201904)
- National Natural Science Foundation of China (81903763)
- China Postdoctoral Science Foundation (2019M661312)
- Natural Science Foundation of Heilongjiang Province (YQ2019H005)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Keywords
- JAK/STAT signaling, JAK inhibitors, STAT proteins, JAK kinases, inflammatory diseases, cancer, immune regulation, signaling crosstalk, cell proliferation and differentiation, apoptosis
- MeSH terms
- Animals, Disease Models, Animal, Humans, Immune System Diseases, Inflammation, Signal Transduction, Cytokines, Protein Kinase Inhibitors, STAT Transcription Factors, Janus Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review